GSK plc GLAXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 46.45% | 96.69% | 131.02% | 128.01% | -13.09% |
| Total Depreciation and Amortization | -67.67% | -51.66% | -32.40% | -4.46% | 21.81% |
| Total Amortization of Deferred Charges | 8.28% | 8.28% | 8.28% | 7.16% | 7.16% |
| Total Other Non-Cash Items | 48.32% | 183.44% | 93.90% | 887.79% | 127,132.47% |
| Change in Net Operating Assets | -0.94% | -1,242.16% | -758.54% | -216.54% | -163.49% |
| Cash from Operations | 11.43% | 20.06% | 22.17% | 8.83% | 6.80% |
| Capital Expenditure | -13.08% | -4.87% | 0.20% | -1.41% | -1.18% |
| Sale of Property, Plant, and Equipment | -26.24% | -19.37% | -61.58% | 573.08% | 230.74% |
| Cash Acquisitions | -265.16% | -173.15% | -113.48% | -134.05% | -6.20% |
| Divestitures | 820.64% | 1,548.03% | -56.85% | -73.25% | -105.22% |
| Other Investing Activities | 57.48% | -3,881.68% | -233.00% | -165.01% | -159.13% |
| Cash from Investing | -36.04% | -114.29% | -248.40% | -3,618.95% | -1,043.99% |
| Total Debt Issued | -52.08% | -32.15% | 138.18% | 382.68% | 300.74% |
| Total Debt Repaid | 66.94% | 30.48% | 29.42% | -0.43% | -23.56% |
| Issuance of Common Stock | -33.33% | -21.43% | -25.00% | -33.33% | -25.00% |
| Repurchase of Common Stock | -48.89% | -489.47% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.86% | -9.60% | -8.32% | -8.63% | -8.80% |
| Other Financing Activities | -16.28% | 18.38% | -12.53% | -44.70% | -7.66% |
| Cash from Financing | -13.60% | -58.30% | 17.15% | 47.55% | 52.37% |
| Foreign Exchange rate Adjustments | 121.85% | 88.16% | 66.09% | 133.10% | -77.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -203.07% | -169.84% | -148.12% | -2,699.00% | 352.82% |